AstraZeneca and Sanofi Beyfortus to dominate RSV market in China: GlobalData EP News Bureau Jan 31, 2024 In 2017, Sanofi entered into a collaboration agreement with MedImmune (AstraZeneca) to jointly develop and commercialise Beyfortus